Our study elucidated the involvement of the SPANXA2-OT1-miR-338-IL-8 axis in CAD, specially, its role in inflammation, suggesting that SPANXA2-OT1 may act as a therapeutic target for aberrant macrophage functions. Here, SPANXA2 is linked to coronary artery disorder.